2-Naphthylamine, a compound found in cigarette smoke, decreases both monoamine oxidase A and B catalytic activity

Life Sciences

Volumn 68, Issue 11, 2001, Pages 1231-1241

  Hauptmann, Nils ^a,b   Shih, Jean Chen ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NeoTherapeutics Inc   (United States)

Author keywords

Cigarette; Monoamine oxidase (MAO); Parkinson's disease; Smoking

Indexed keywords

2 NAPHTHYLAMINE; AMINE OXIDASE (FLAVIN CONTAINING);

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOPAMINE BRAIN LEVEL; ENZYME ACTIVITY; ENZYME LOCALIZATION; MALE; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; SEROTONIN BRAIN LEVEL; SMOKING;

2-NAPHTHYLAMINE; ANIMALS; BRAIN; MALE; MICE; MITOCHONDRIA; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PLANTS, TOXIC; SMOKE; TOBACCO;

GYMNOMYZA SAMOENSIS; PISUM SATIVUM;

EID: 0035793234     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)01022-5     Document Type: Article

References (50)

1. Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem
2. Differential age-related changes of MAO-A and MAO-B in mouse brain and peripheral organs
3. The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline
4. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs
5. The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions
6. Biological and behavioral consequences of alterations in monoamine oxidase activity
7. Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression
8. Reversible monoamine oxidase-A inhibitors in resistant major depression
9. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAO A
10. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase
11. Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type
12. Brain and brain monoamine oxidase in aging and in dementia of Alzheimer's type
13. Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease
14. The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
15. Brain monoamine oxidase A inhibition in cigarette smokers
16. Inhibition of monoamine oxidase B in the brains of smokers
17. Low platelet monoamine oxidase activity in cigarette smokers
18. Monoamine oxidase A and B activities in heavy smokers
19. The pathobiology of Parkinson's disease: Biochemical aspects of dopamine neuron senescence
20. The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA
21. Increased stress response and β-phenylethylamine in MAO B-deficient mice
22. Platelet monoamine oxidase: Low activity in cigarette smokers
23. Monoamine oxidase: Associations with alcohol dependence, smoking and other measures of psychopathology
24. Effects of tobacco smoke constituents on MPTP-induced toxicity and monoamine oxidase activity in the mouse brain
25. Biogenic amine adducts, monoamine oxidase inhibitors, and smoking
26. Inhibition of brain monoamine oxidase by adducts of 1,2,3,4,-tetrahydroisoquinoline with components of cigarette smoke
27. Smoking, smoking cessation, and major depression
28. The potentiation of the anti akinetic effect after l-dopa treatment by an inhibitor of MAO-B, deprenil
29. Pharmacological basis of the therapeutic effect of (-)deprenyl in age-related neurological diseases
30. Neuropsychological effects of l-deprenyl in Alzheimer's type dementia
31. Effects of a MAO-B inhibitor in the treatment of Alzheimer disease
32. Chemical studies on tobacco smoke LXIV. On the analysis of aromatic amines in cigarette smoke
33. Quantitative determination of 1-naphthylamine and 2-naphthylamine in cigarette smoke
34. Chemical carcinogens
35. 2-Ethynylnaphthalene as a mechanism-based inactivator of the cytochrome P-450 catalyzed N-oxidation of 2-naphthylamine
36. Prostaglandin H synthase-catalyzed metabolism and DNA binding of 2-naphthylamine
37. Prostaglandin H synthase-catalyzed ring oxygenation of 2-naphth-ylamine: Evidence for two distinct oxidation pathways
38. Preparation and properties of brain mitochondria
39. Ischemia/reperfusion-induced injury of forebrain mitochondria and protection by ascorbate
40. Photoaffinity labeling of human placental monoamine oxidase-A by 4-fluoro-3-nitrophenyl azide
41. Irreversible inhibition of monoamine oxidase by some components of cigarette smoke
42. Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue?
43. Alcohol and tobacco consumption as risk factors for Alzheimer's disease: A collaborative re-analysis of case-control studies
44. Epidemiologic studies of Parkinson's disease: A survey and explanatory hypothesis
45. Hemoglobin adducts of aromatic amines: Associations with smoking status and type of tobacco
46. N-acetyltransferase phenotype and risk in urinary bladder cancer: Approaches in molecular epidemiology
47. Generation of hydrogen peroxide and superoxide anion from active metabolites of naphthylamines and aminoazo dyes: Its possible role in carcinogenesis
48. Clinical pharmacology of monoamine oxidase inhibitors
49. Comparison of the monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects
50. Primary aromatic amines from side-stream cigarette smoke are common contaminants of indoor air